Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.
Lifetime Brands rated Hold after a 113% YTD rally; fairly valued at 7.6x EV/EBITDA. Click here to read more about LCUT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results